Y-mabs (YMAB) Stock Price Today, Chart, Quote and News | baraka

Y

Y-mabs (YMAB)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About Y-mabs (YMAB)

Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing the therapeutic products for the treatment of cancer. Its product pipeline includes naxitamab and omburtamab. The Compan... Read more

Open
USD17.15
High
USD17.38
Low
USD16.80
52 Week High
USD20.90
Monthly Return
19.20%
Revenue
85M

Daily Vol.
13.00
Avg. Daily Vol.
326.05k
Market Cap.
752M
52 Week Low
4.60
Annual Return
149.50%

Stock News

Warren Buffett says one question posed by AI has stumped economists for a century

Warren Buffett says one question posed by AI has stumped economists for a century

CNBC

Trump trial: Ex-president posts — then quickly deletes — message about witness schedule, hush money judge

Trump trial: Ex-president posts — then quickly deletes — message about witness schedule, hush money judge

CNBC

Bitdeer Announces April 2024 Operations Updates

Bitdeer Announces April 2024 Operations Updates

Yahoo

Truist sells nearly $28 billion of low-yield investments

Truist sells nearly $28 billion of low-yield investments

Yahoo

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Build Your Long Term Wealth

Build Your Long Term Wealth

A modern investment app with fair pricing.

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Not sure which stock to invest in?

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.